EUVIMEDEUVIMED entdecken
Crossref

NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death

Yun Huang, Dengshuai Wei, Bin Wang, Dongsheng Tang, Ailan Cheng, Shengjun Xiao, Yingjie Yu, Weiguo Huang

Acta Biomaterialia · 2023

DOI: 10.1016/j.actbio.2023.02.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023. Verfasst von Yun Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Tumor Immunity and Microenvironment Regulation, Guilin Medical University, Guilin 541199, China; Cancer Research Institute,…. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a DNA damaging agent, oxaliplatin (OXA) can induce immunogenic cell death (ICD) in tumors to activate the immune system. However, the DNA damage induced by OXA is limited and the ICD effect is not strong enough to enhance anti-tumor efficacy. Here, we propose a strategy to maximize the ICD effect of OXA through the mild hyperthermia generated by nanoparticles with a platinum (IV) prodrug of OXA (Pt(IV)-C16) and a near-infrared-II (NIR-II) photothermal agent IR1061 upon the irradiation of NIR-II light. The mild hyperthermia (43 °C) holds advantages in two aspects: 1) increase the Pt-DNA cross-linking, leading to enhanced DNA damage and apoptosis; 2) induce stronger ICD effects for cancer immunotherapy. We demonstrated that, compared with OXA and photothermal therapy of IR1061 alone, these nanoparticles under NIR-II light irradiation can significantly improve the anti-cancer efficacy against triple-negative breast cancer 4T1 tumor. This new strategy provides an effective way to improve the therapeutic outcome of OXA. STATEMENT OF SIGNIFICANCE: OXA could induce immunogenic cell death (ICD) via stimulating immune responses by increasing tumor cell stress and death, which triggers tumor-specific immune responses to achieve immunotherapy. However, due to the insufficient Pt-DNA crosslinks, the ICD effect triggered by OXA cannot induce robust immune response. Mild hyperthermia has great potential to maximize the therapeutic outcome of oxaliplatin by increasing the Pt-DNA cross-linking to augment the immunoresponse for enhanced cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanoparticlesHumansOxaliplatinImmunogenic Cell DeathBoratesImmunotherapyDNACell Line, TumorPyrans

Stichwörter der Autor:innen

DNA damageImmunogenic cell deathImmunotherapyMild hyperthermiaOxaliplatin

Substanzen

OxaliplatinBoratesDNAIR1061Pyrans

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Tumor Immunity and Microenvironment Regulation, Guilin Medical University, Guilin 541199, China; Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 42100…
  • Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
  • Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, China.
  • Guangxi Key Laboratory of Tumor Immunity and Microenvironment Regulation, Guilin Medical University, Guilin 541199, China.
  • State Key Laboratory of Organic-Inorganic Composites; Beijing Laboratory of Biomedical Materials; Beijing University of Chemical Technology, Beijing 100029, China. Electronic address: yuyingjie@mail.buct.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, Y., Wei, D., Wang, B., Tang, D., Cheng, A., Xiao, S., Yu, Y., & Huang, W. (2023). NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2023.02.012

Vancouver

Huang Y, Wei D, Wang B, Tang D, Cheng A, Xiao S, et al. NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death. Acta Biomaterialia. 2023. doi:10.1016/j.actbio.2023.02.012

BibTeX
@article{Huang2023,
  author = {Huang, Yun and Wei, Dengshuai and Wang, Bin and Tang, Dongsheng and Cheng, Ailan and Xiao, Shengjun and Yu, Yingjie and Huang, Weiguo},
  title = {NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death},
  journal = {Acta Biomaterialia},
  year = {2023},
  doi = {10.1016/j.actbio.2023.02.012}
}
Kostenlos starten →